Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL04
- Pharmacological subgroupL04A
- Chemical subgroupL04AJ
- Chemical substanceL04AJ08Iptacopan
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Brazil
Anvisa · 1 registration
Canada
Health Canada · 1 registration
Spain
AEMPS · 1 registration
European Union
EMA · 1 registration
Croatia
HALMED · 1 registration
At a glance
- ATC code
- L04AJ08
- Registers
- 8
- Registrations
- 8
- With their own page
- 8
- Companies
- 5
All medicines with Iptacopan
Human medicines from every register that match Iptacopan by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
8 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Fabhalta | United States | 200MG BASE | capsule | Marketed | Novartis |
| Fabhalta | European Union | Authorised | Novartis Europharm Limited | ||
| Fabhalta 200 MG Capsulas Duras | Spain | 225,80 mg | cápsula dura | Marketed | Novartis Europharm Limited |
| FABHALTA 200 mg harde capsules | Netherlands | Capsule, hard | Authorised | Novartis Europharm Limited | |
| Fabhalta | Canada | 200 MG | Capsule | Marketed | Novartis Pharmaceuticals Canada INC |
| Fabhalta | Brazil | Authorised | Novartis Biociencias S.A | ||
| Fabhalta Capsule 200mg | Singapore | 200.0mg | capsule | Authorised | Novartis (Singapore) Pte LTD |
| Fabhalta | Croatia | Authorised |